Efficacy of Stiripentol Beyond Dravet Syndrome: A Retrospective Medical Record Review of Patients with Drug-Resistant Epilepsies
Add-on stiripentol provides overall improvement in different seizure types and non-seizure manifestations for paediatric patients with drug-resistant epilepsy, including epileptic syndromes besides DS, and appeared effective in acute treatment of SE. Stiripentol was generally well tolerated.
Authors
- Victor Miguel Soto Insuga (ORCID: https://orcid.org/0000-0002-8358-2901)
- Elena González Alguacil (ORCID: https://orcid.org/0009-0005-0247-9187)
- Nuria Lamagrande‐Casanova (ORCID: https://orcid.org/0009-0007-6394-6206)
- Elena Cardenal‐Muñoz (ORCID: https://orcid.org/0000-0003-4757-9323)
- Anna Duat Rodríguez (ORCID: https://orcid.org/0000-0003-1532-4123)
- María Ballarà-Petitbò (ORCID: https://orcid.org/0000-0002-2507-3252)
- Juan José Garcı́a-Peñas (ORCID: https://orcid.org/0000-0002-6292-3287)
- Cristina Benítez-Provedo
Institutions
- Biocodex (France) (FR)
- Menéndez Pelayo International University (ES)
Publication Details
- Journal
- Neurology and Therapy
- Published
- 2025-05-03
- DOI
- https://doi.org/10.1007/s40120-025-00755-5
- Citations
- 4
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.88